Back to Results
First PageMeta Content
Heparins / Dalteparin sodium / Abraxis BioScience / Fludarabine / Genta / Paclitaxel / Protein-bound paclitaxel / B-cell chronic lymphocytic leukemia / Pulmonary embolism / Chemistry / Medicine / Organic chemistry


Disclosure Document for an 18 U
Add to Reading List

Document Date: 2006-08-23 08:39:07

Open Document

File Size: 11,78 KB

Share Result on Facebook

Company

Pfizer Inc. / Interest Nature Magnitude Unrelated Consulting / Genta Inc. / Abraxis BioScience Inc. / /

Currency

USD / /

Event

FDA Phase / /

IndustryTerm

treatment of patients with chronic lymphocytic leukemia / treatment of node-positive breast cancer / /

MedicalCondition

node-positive breast cancer / cancer / pulmonary embolism / chronic lymphocytic leukemia / symptomatic venous thromboembolism / proximal deep vein thrombosis / /

Organization

FDA / Oncologic Drugs Advisory Committee / /

Person

Ronald Bukowski / /

Position

year Unrelated Speaker / /

Product

Abraxane / Fragmin / paclitaxel / cyclophosphamide / Genasense (oblimersen sodium) Injection / /

SocialTag